Taysha Gene Therapies
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Taysha Gene Therapies generated cash of -$73,018,000, which is more than the previous year. Cash used in financing activities reached the amount of $136,393,000 last year. Net change in cash is therefore $56,023,000.
Cash Flow
| 2019 | 135K | 0 | 0 |
|---|---|---|---|
| 2020 | -30.72M | -9.08M | 291.06M |
| 2021 | -117.04M | -21.55M | 39.08M |
| 2022 | -88.39M | -24.93M | 52.09M |
| 2023 | -73.01M | -7.35M | 136.39M |
TSHA Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 90.51M | 151.74M | 251.25M | 0 | 0 |
Operating activities | |||||
Net income | -111.56M | -166.01M | -174.52M | -60.01M | -4.46M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 1.37M | 1.17M | 492K | 9K | 0 |
Stock-based compensation expense | 7.90M | 18.04M | 18.18M | 3.35M | 0 |
| Deferred income tax benefit | 7.90M | 18.04M | 18.18M | 3.35M | 0 |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -2.29M | -7.80M | 14.49M | 1.96M | 0 |
Cash generated by operating activities | -73.01M | -88.39M | -117.04M | -30.72M | 135K |
Investing activities | |||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -3.86M | -24.86M | -21.55M | -9.08M | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -7.35M | -24.93M | -21.55M | -9.08M | 0 |
Financing activities | |||||
Common Stock Issued | 140.79M | 53.24M | -360K | 165.85M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -3.45M | 0 | -39.95M | -1.67M | 0 |
Cash used in financing activities | 136.39M | 52.09M | 39.08M | 291.06M | 0 |
Net Change In Cash | 56.02M | -61.22M | -99.51M | 251.25M | 135K |
Cash at end of period | 146.54M | 90.51M | 151.74M | 251.25M | 135K |
| Data source | Data source | Data source | Data source |